CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde may be out of specification in the affected lots.

Product CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE Issue Health products - Product quality What to do Consult your healthcare provider for any health concerns. Audience Healthcare Industry

The level of the degradation product Benzaldehyde may be out of specification in the affected lots.

Verify if your product is affected. Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns. Contact the recalling firm if you have any questions about the recall. Report any health product related side effects to Health Canada. Report any other health product safety complaints to Health Canada.

RA-82501